Marc Sze
Principal Scientist Merck & Co
Dr. Sze has spent over 7 years at Merck supporting early discovery efforts in Immuno-oncology and Immunology therapeutics areas. His team specializes in using multiple omics technologies to help research teams find novel targets, create PK/PD biomarkers for pipeline programs, and develop cutting edge methods and pipelines. His team’s work spans genomics, genetics, and proteomics-based technologies and approaches.
Seminars
Thursday 2nd April 2026
Does Resolution Depth Still Matter in the Era of Big Data & “Artificial Intelligence”
8:00 am
- What is big data and what is generally considered big data. This section will provide a quick overview of how big data has evolved and how we classify “big data” has changed over time
- Learn about different issues that can limit the utility of genomics data and is normally not considered when aggregating data collections together
- Discover how assumptions made about the biology and the AI/ML methods being employed may lead to possible blind spots for accurate discovery
Thursday 2nd April 2026
Panel Discussion: Enabling Precision Medicine in IBD Through Advanced Data Collaboratio
8:30 am
- Explore how different stakeholders, clinicians, technology providers, and patient organizations define the role of data collaboration in advancing precision medicine today
- Why is a data-driven precision medicine strategy critical now in IBD, and what are the clinical and patient consequences if collaboration doesn’t happen early enough?
- What are the biggest barriers and opportunities in standardising endpoints, clinical assumptions, metadata, and biospecimen strategies across real-world and clinical trial datasets?
- As AI becomes embedded in drug discovery and development, how does data quality, particularly in real-world versus clinical trial data, limit or enable its impact?
- What practical steps can the ecosystem take to translate collaborative data efforts into actionable precision medicine, from trial design and regulatory strategy to prescribing and patient access?
